OVARIAN ENDOMETRIOID TUMOR
Clinical trials for OVARIAN ENDOMETRIOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for recurrent ovarian cancer in early trial
Disease control OngoingThis early-phase study tests a new drug (berzosertib) added to standard chemotherapy for women with ovarian, peritoneal, or fallopian tube cancer that has returned after initial treatment. The goal is to find the safest dose and see if the combination works better than chemo alon…
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New drug combo could offer alternative to chemo for recurrent ovarian cancer
Disease control OngoingThis phase 3 study tested whether the targeted drugs olaparib (alone or combined with cediranib) work better than standard platinum-based chemotherapy for women with ovarian, fallopian tube, or primary peritoneal cancer that came back after initial treatment. About 579 women with…
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC